Host Cell Metabolism Goes Viral: Unveiling How HEV Hijacks Your Cells
Published in Chemistry, Microbiology, and Cell & Molecular Biology
Our latest study (Glaziou et al., 2026, Mol Cell Life Sci) reveals that HEV hijacks host cell metabolism to fuel its replication:
- TCA cycle, mitochondrial oxidative phosphorylation (OXPHOS), fatty acid metabolism, and β-oxidation, are extensively rewired.
- Lipid storage organelles expand, long-chain neutral lipids accumulate, and pro-inflammatory oxylipins surge.
- HEV relies on lipid-fuelled OXPHOS rather than glycolysis.
- Distinct metabolic programs for HEV-1 versus HEV-3, aligning with their differential pathogenicity.
These findings highlight critical host metabolic vulnerabilities exploited by HEV and provide a roadmap for targeting metabolic hubs as therapy.
Interestingly, while our previous work in placental models (Gouilly et al., 2018, Nat Commun) showed HEV-1 triggers inflammatory damage at the maternal-fetal interface, the placenta is a highly active metabolic organ, and how HEV reshapes its metabolism remains an exciting question for future studies.
Takeaway: HEV doesn’t just infect—it reprograms, fuels, and manipulates host metabolism to thrive. Understanding these strategies could point to novel therapeutic interventions.

Follow the Topic
-
Cellular and Molecular Life Sciences
Cellular and Molecular Life Sciences (CMLS) is a multidisciplinary Open Access journal covering the latest aspects of biological and biomedical research.
Related Collections
With Collections, you can get published faster and increase your visibility.
TME-Driven Metastasis and Adaptive Phenotypes
The tumor microenvironment (TME) is a dynamic and multifaceted ecosystem that shapes nearly every aspect of cancer progression, from early tumor evolution to metastatic spread and therapeutic response. Dynamic interactions between tumor cells, stromal components, immune infiltrates, and extracellular matrix structures not only cell migration and invasion but also broader adaptive phenotypes such as metabolic rewiring, immune escape, therapy resistance, and phenotypic plasticity. Recent advances in single-cell omics, live-cell imaging, spatial transcriptomics, and functional modeling systems (e.g. organoids, organ-on-chip) have illuminated how bidirectional communication within the TME governs these behaviors.
This collection invites cutting-edge research and comprehensive reviews that dissect the cellular and molecular mechanisms by which the TME drives tumor dissemination and adaptive cancer cell states. We welcome interdisciplinary contributions spanning molecular oncology, immunology, systems biology, and bioengineering, with an emphasis on translational insights that inform therapeutic targeting of TME-driven and immune-regulatory pathways in cancer.
Topics of Interest
- Molecular mechanisms of tumor cell migration and invasion
- Crosstalk between tumor cells, fibroblasts, and immune cells in the TME
- Role of cytokines, chemokines, and extracellular vesicles in cell migration
- Immunomodulatory effects of the TME on metastatic potential
- ECM remodeling and mechanotransduction in cancer cell motility
- Computational and imaging approaches to study cell migration in vivo
- Targeting migration-associated signaling (e.g., EMT, integrins, PI3K, Rho GTPases)
- Interplay between immune checkpoint pathways and migratory signaling
- Tumor-derived exosomes and their role in pre-metastatic niche formation
- Translational strategies for inhibiting TME-driven metastasis
Publishing Model: Open Access
Deadline: Dec 27, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in